Japan Tissue Engineering (7774) · RiskDropped
Industry-wide loss of trust due to medical accidents involving regenerative medicine
First written in FY2018. 1 of 2 entries say "Dropped", first in FY2024. Latest entry: FY2024.
2entries
7years
0from disclosures
How it moved
Same theme, other companies
Reputational damage caused by medical accidents and illegal acts in the regenerative medicine industryA theme 3 companies write about · 3 as a headwind · 0 as a tailwind
0 other companies' latest entry also says "Dropped".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2024DroppedAnnual reportIn the FY2024 business risk section, no standalone item can be identified addressing the risk of declining confidence in the regenerative medicine industry as a whole due to medical accidents at other companies.
- FY2018First statedAnnual report
「If a medical accident or similar incident related to regenerative medicine occurs, market confidence in the regenerative medicine industry and regenerative medicine products as a whole may be lost as a result of the negative image, even if the Company's products or services are not directly involved. This could affect the Company's business strategy and business performance.」
The potential for an impact through declining confidence in the regenerative medicine industry as a whole was newly disclosed, even where an accident was not directly related to the Company's products or services.